Mesenchymal stem cell-based gene therapy: A promising therapeutic strategy

References

• Abdi R, Fiorina P, Adra CN, Atkinson M, Sayegh MH. 2008. Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes. 57:1759–1767.
   PubMed Web of Science ®Google Scholar
• Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, et al. 2000. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA. 97:12846–12851.
   PubMed Web of Science ®Google Scholar
• Aiuti A, Slavin S, Aker M, Ficara F, Deola S, Mortellaro A, et al. 2002. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science. 296:2410–2413.
   PubMed Web of Science ®Google Scholar
• Bao Q, Zhao Y, Renner A, Niess H, Seeliger H, Jauch KW, Bruns CJ. 2010. Cancer stem cells in pancreatic cancer. Cancers. 2:1629–1641.
   PubMedGoogle Scholar
• Benedetti S, Pirola B, Pollo B, Magrassi L, Bruzzone MG, Rigamonti D, et al. 2000. Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med. 6:447–450.
   PubMed Web of Science ®Google Scholar
• Brooke G, Cook M, Blair C, Han R, Heazlewood C, Jones B, et al. 2007. Therapeutic applications of mesenchymal stromal cells. Semin Cell Dev Biol. 18:846–858
   PubMed Web of Science ®Google Scholar
• Caplan AI. 1991. Mesenchymal stem cells. J Orthop Res. 9:641–650
   PubMed Web of Science ®Google Scholar
• Dao MA, Pepper KA, Nolta JA. 1997. Long-term cytokine production from engineered primary human stromal cells influences human hematopoiesis in an in vivo xenograft model. Stem Cells. 15:443–454.
   PubMed Web of Science ®Google Scholar
• Dimmeler S, Zeiher AM, Schneider MD. 2005. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest. 115:572–583.
   PubMed Web of Science ®Google Scholar
• Djouad F, Bony C, Apparailly F, Louis-Plence P, Jorgensen C, Noel D. 2006. Earlier onset of syngenic tumors in the presence of mesenchymal stem cells. Transplantation. 82:1060–1066.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy. 8:315–317.
   Google Scholar
• Drosse I, Volkmer E, Capanna R, De Biase P, Mutschler W, Schieker M. 2008. Review tissue engineering for bone defect healing: an update on a multi-component approach. Injury. 39:9–20.
   PubMed Web of Science ®Google Scholar
• Dvorak HF. 1986. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing N Engl J Med. 315:1650–1659.
   Google Scholar
• English K, Ryan JM, Tobin L, Murphy MJ, Barry FP, Mahon BP. 2009. Cell contact, rostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4 + CD25(High) forkhead box P3 + regulatory T cells. Clin Exp Immunol. 156:149–160.
   PubMed Web of Science ®Google Scholar
• Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. 1974. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation. 17:331–340.
   PubMed Web of Science ®Google Scholar
• Friedenstein AJ. 1991. Osteogenic stem cells in the bone marrow. Bone Miner. 7:243–272.
   Google Scholar
• Fuchs D, Fuchs LS, Thompson A, Al Otaiba S, Yen L, Braun M, O’Connor RE. 2001. Is reading important in reading-readiness programs? A randomized field trial with teachers as program implementers. J Educ Psychol. 93:251–267.
   Web of Science ®Google Scholar
• Galderisi U, Giordano A, Paggi MG. 2010. The bad and the good of mesenchymal stem cells in cancer: boosters of tumor growth and vehicles for targeted delivery of anticancer agents. World J Stem Cells. 2:5–12.
   PubMedGoogle Scholar
• García-Castro J, Trigueros C, Madrenas J, Pérez-Simón JA, Rodriguez R, Menendez P. 2008. Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool. J Cell Mol Med. 12:2552–2565.
   PubMed Web of Science ®Google Scholar
• Gotherstrom C, West A, Liden J, Uzunel M, Lahesmaa R, Le Blanc K. 2005. Difference in gene expression between human fetal liver and adult Bone marrow mesenchymal stem cells. Haematologica. 90:1017–1026.
   PubMed Web of Science ®Google Scholar
• Gracey Maniar LE, Maniar JM, Chen ZY, Lu J, Fire AZ, Kay MA. 2013. Minicircle DNA vectors achieve sustained expression reflected by active chromatin and transcriptional level. Mol Ther..21:131–138.
   PubMed Web of Science ®Google Scholar
• Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, Flint AF, et al. 1999. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature. 401:390–394.
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina S, Le Diest F, Carlier F, Bouneaud C, Hue C, De Villartay JP, et al. 2002. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med. 346:1185–1193.
   PubMed Web of Science ®Google Scholar
• Herrera MB, Bussolati B, Bruno S, Morando L, Mauriello-Romanazzi G, Sanavio F, et al. 2007. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int. 72:430–441.
   PubMed Web of Science ®Google Scholar
• Herrlinger U, Woiciechowski C, Sena-Esteves M, Aboody KS, Jacobs AH, Rainov NG, et al. 2000. Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas. Mol Ther. 1:347–357.
   PubMed Web of Science ®Google Scholar
• Hodgkinson CP, Gomez JA, Mirotsou M, Dzau VJ. 2010. Genetic engineering of mesenchymal stem cells and its application in human disease therapy. Hum Gene Ther. 21:1513–1526
   PubMed Web of Science ®Google Scholar
• Huang H, Chen L, Sanberg P. 2010. Cell therapy from bench to bedside translation in CNS neurorestoratology era. Cell Med. 1:15–46.
   PubMedGoogle Scholar
• Jabbarzadeh E, Starnes T, Khan YM, Jiang T, Wirtel AJ, Deng M, et al. 2008. Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: a combined gene therapy-cell transplantation approach. Proc Natl Acad Sci USA. 105:11099–11104.
   PubMed Web of Science ®Google Scholar
• Ji JF, He BP, Dheen ST, Tay SS. 2004. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells..22:415–427.
   PubMed Web of Science ®Google Scholar
• Jones BJ, McTaggart SJ. 2008. Immunosuppression by mesenchymal stromal cells: from culture to clinic. Exp Hematol. 36:733–741.
   PubMed Web of Science ®Google Scholar
• Karp JM, Teo G. 2009. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell. 4:206–216.
   PubMed Web of Science ®Google Scholar
• Khakoo AY, Pati S, Anderson SA, Reid W, Elshal MF, Rovira II, et al. 2006. Human mesenchymal stem cells exert potent anti-tumorigenic effects in a model of Kaposi's sarcoma. J Exp Med. 203:1235–1247.
   PubMed Web of Science ®Google Scholar
• Kidd S, Spaeth E, Klopp A, Andreeff M, Hall B, Marini FC. 2008. The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe. Cytotherapy. 10:657–667.
   PubMed Web of Science ®Google Scholar
• Kim SW, Kim SJ, Park SH, Yang HG, Kang MC, Choi YW, et al. 2013. Complete regression of metastatic renal cell carcinoma by multiple injections of engineered mesenchymal stem cells expressing dodecameric TRAIL and HSV-TK. Clin Cancer Res. 19:415–427.
   PubMed Web of Science ®Google Scholar
• Klopp AH, Gupta A, Spaeth E, Andreeff M, Marini F III. 2011. Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Stem Cells. 29: 11–19.
   PubMed Web of Science ®Google Scholar
• Kucerova L, Altanerova V, Matuskova M, Tyciakova S, Altaner C. 2007. Adipose tissuederived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res. 67:6304–6313.
   PubMed Web of Science ®Google Scholar
• Li GC, Ye QH, Xue YH, Sun HJ, Zhou HJ, Ren N, et al. 2010. Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line. Cancer Sci. 101: 2546–2553.
   PubMed Web of Science ®Google Scholar
• Li L, Tian H, Chen Z, Yue W, Li S, Li W. 2011. Inhibition of lung cancer cell proliferation mediated by human mesenchymal stem cells. Acta Biochim Biophys Sin. 43:143–148.
   Google Scholar
• Li Y, Tew SR, Russell AM, Gonzalez KR, Hardingham TE, Hawkins RE. 2004. Transduction of passaged human articular chondrocytes with adenoviral, retroviral, and lentiviral vectors and the effects of enhanced expression of SOX9. Tissue Eng. 10:575–584.
   PubMedGoogle Scholar
• Ma Y, Ramezani A, Lewis R, Hawley RG, Thomson JA. 2003. High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells. 21:111–117.
   PubMed Web of Science ®Google Scholar
• Marlow LAV, Waller J, Wardle J. 2007. Public awareness that HPV is a risk factor for cervical cancer. Br J Cancer. 97:691–694.
   PubMed Web of Science ®Google Scholar
• Matsumoto R, Omura T, Yoshiyama M, Hayashi T, Inamoto S, Koh KR, et al. 2005. Vascular endothelial growth factor-expressing mesenchy-mal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscler Thromb Vasc Biol. 25:1168–1173.
   PubMed Web of Science ®Google Scholar
• Maumus M, Guérit D, Toupet K, Jorgensen C, Noël D. 2011. Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology. Stem Cell Res Ther. 2:14.
   PubMed Web of Science ®Google Scholar
• Minayi N, Alizadeh S, Dargahi H, Soleimani M, Khatib ZK, Tayebi B, et al. 2014. The effect of miR-210 up-regulation on proliferation and survival of mouse bone marrow derived mesenchymal stem cell. Int J Hematol Oncol Stem Cell Res. 8:15–23.
   PubMedGoogle Scholar
• Mohammadian M, Shamsasenjan K, Lotfi Nezhad P, Talebi M, Jahedi M, Nickhah H, et al. 2013. Mesenchymal stem cells: new aspect in cell-based regenerative therapy. Adv Pharm Bull. 3:433–437.
   PubMedGoogle Scholar
• Muschler GF, Nakamoto C, Griffith LG. 2004. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am. 86A:1541–1558.
   Web of Science ®Google Scholar
• Nauta AJ, Fibbe WE. 2007. Immunomodulatory properties of mesenchymal stromal cells. Blood. 110:3499–3506.
   PubMed Web of Science ®Google Scholar
• Nolta JA, Hanley MB, Kohn DB. 1994. Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene transduction of long-lived progenitors. Blood. 83:3041–3051.
   PubMed Web of Science ®Google Scholar
• Nowakowski A, Andrzejewska A, Janowski M, Walczak P, Lukomska B. 2013. Genetic engineering of stem cells for enhanced therapy. Acta Neurobiol Exp. 73:1–18.
   PubMed Web of Science ®Google Scholar
• Otsu K, Das S, Houser SD, Quadri SK, Bhattacharya S, Bhattacharya J. 2009. Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells. Blood. 113:4197–4205.
   PubMed Web of Science ®Google Scholar
• Penna C, Raimondo S, Ronchi G, Rastaldo R, Mancardi D, Cappello S, et al. 2008. Early homing of adult mesenchymal stem cells in normal and infarcted isolated beating hearts. J Cell Mol. 12:507–521.
   PubMed Web of Science ®Google Scholar
• Pereira RF, O’Hara MD, Laptev AV, Halford KW, Pollard MD, Class R, et al. 1998. Marrow stromal cells as a source of progenitor cells for onhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfect. Proc Natl Acad Sci USA. 95:1142–1147.
   PubMed Web of Science ®Google Scholar
• Qiao L, Xu Z, Zhao T, Zhao Z, Shi M, Zhao RC, et al. 2008. Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Res. 18:500–507.
   PubMed Web of Science ®Google Scholar
• Ramasamy R, Lam EW, Soeiro I, Tisato V, Bonnet D, Dazzi F. 2007. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia. 21:304–310.
   PubMed Web of Science ®Google Scholar
• Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lönnies H, et al. 2006. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation. 81:1390–1397.
   PubMed Web of Science ®Google Scholar
• Salem HK, Thiemermann C. 2010. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells. 28:585–596.
   PubMed Web of Science ®Google Scholar
• Secchiero P, Zorzet S, Tripodo C, Corallini F, Melloni E, Caruso L, et al. 2010. Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated Non-Hodgkin's lymphoma xenografts. PLoS One. 6:e11140.
   Web of Science ®Google Scholar
• Seo SH, Kim KS, Park SH, Suh YS, Kim SJ, Jeun SS, et al. 2011. The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity. Gene Ther. 18:488–495.
   PubMed Web of Science ®Google Scholar
• Spaeth E, Klopp A, Dembinski J, Andreeff M, Marini F. 2008. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther. 15:730–738.
   PubMed Web of Science ®Google Scholar
• Tian LLH, Yue W, Zhu F, Li S, Li W. 2011. Human mesenchymal stem cells play a dual role on tumor cell growth in vitro and in vivo. J Cell Physiol. 226:1860–1867.
   PubMed Web of Science ®Google Scholar
• Tögel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. 2005. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol. 289:F31–42.
   PubMed Web of Science ®Google Scholar
• Tuch BE. 2006. Stem cells a clinical update. Aust Fam Physician. 35:719–721.
   PubMedGoogle Scholar
• Uccelli A, Pistoia V, Moretta L. 2007. Mesenchymal stem cells: a new strategy for Immunosuppression. Trends Immunol. 28:219–226.
   PubMed Web of Science ®Google Scholar
• Wang H, Cao F, De A, Cao Y, Contag C, Gambhir SS, et al. 2009. Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by ioluminescence imaging. Stem Cells. 27:1548–1558.
   PubMed Web of Science ®Google Scholar
• Will J, Melcher R, Treul C, Travitzky N, Kneser U, Polykandriotis E, et al. 2008. Porous ceramic bone scaffolds for vascularized bone tissue regeneration. J Mater Sci Mater Med. 19:2781–2790.
   PubMed Web of Science ®Google Scholar
• Wong RS. 2011. Mesenchymal stem cells: angels or demons? J Biomed Biotechnol. 2011: 459510.
   PubMedGoogle Scholar
• Yagi H, Soto-Gutierrez A, Parekkadan B, Kitagawa Y, Tompkins RG, Kobayashi N, et al. 2010. Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplant. 19:667.
   PubMed Web of Science ®Google Scholar
• Yu JM, Jun ES, Bae YC, Jung JS. 2008. Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells Dev. 17:463–473.
   PubMed Web of Science ®Google Scholar
• Zare M, Soleimani M, Mohammadian M, Akbarzadeh A, Havasi P, Zarghami N. 2014. Efficient biotechnological approach for lentiviral transduction of induced pluripotent stem cells. Artif Cells Nanomed Biotechnol.1–6.
   PubMed Web of Science ®Google Scholar
• Zhu W, Xu W, Jiang R, Qian H, Chen M, Hu J, et al. 2006. Mesenchymal stem cells derived from bone marrow favour tumor cell growth in vivo. Exp Mol Pathol. 80:267–274.
   PubMed Web of Science ®Google Scholar